Intensity Therapeutics, Inc (NASDAQ:INTS) IPO will take place October, 19 on the NASDAQ exchange under the ticker INTS.
The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on April 17, 2023.
See also: Benzinga IPO Calendar
About Intensity Therapeutics, Inc
Intensity Therapeutics, Inc is a clinical-stage biotechnology company whose treatment approach addresses both the regional and systemic nature of a patient's cancer
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
